The Pharma Data

OCTOBER 1, 2021

Currently, the quality dose for all marketed GBCAs, including gadobutrol and gadoterate, is 0.1 Dr. Olaf Weber, Head of Radiology Research and Development at Bayer. About Radiology at Bayer Everyone deserves clear answers about their health, starting with an early and accurate diagnosis. mmol/kg weight. “At

Radiology 52

Radiology Life Science Development Production 52

The Pharma Data

NOVEMBER 19, 2020

He focused on corporate and business unit strategies, organizational transformations, product launches, growth strategies and new market entries. Hojvat served as the director of the Division of Microbiology Devices at the Center for Devices and Radiological Health at the Food and Drug Administration for 12 years. Source link.

Life Science 52

Life Science Research Development Radiology 52

Delveinsight

SEPTEMBER 2, 2021

This designation was based on positive clinical data from the first 21 Impella ECP patients treated as part of an FDA-regulated early feasibility study and will give priority during the Impella ECP’s regulatory review processes comprising of design iterations, clinical study protocols, and pre-market approval (PMA) application.

Marketing 72

Marketing Radiology Drugs Drug Delivery 72

pharmaphorum

MARCH 11, 2021

Diagnostics was never a Cinderella sector; Britain has the fifth largest in vitro diagnostics (IVD) market in Europe, not gigantic but significant nevertheless. Across the UK, radiology departments are understaffed by around 43%, while only 3% of histopathology departments have enough staff to meet clinical demand.

In-Vitro 71

In-Vitro Containment Radiology Life Science 71

XTalks

JUNE 12, 2023

Medtronic’s Hugo Robotic-Assisted Surgery system , released in a limited market in June 2021, has been receiving positive reviews for its performance in various surgeries. Medtronic is optimistic about this opportunity and anticipates high demand across a large global market. billion in 2022, an increase of 1.36 percent from $27.06

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

XTalks

JANUARY 19, 2024

Regulatory bodies have demonstrated preparedness for the surge in radiopharmaceuticals as evidenced by inaugural Chemistry, Manufacturing and Controls (CMC) Development and Readiness Pilot (CDRP) programs to expedite commercial manufacturing, US Food and Drug Administration (FDA) approvals and marketing authorizations.

DNA 66

DNA Radiology FDA Approval Development 66

XTalks

AUGUST 30, 2022

CNS drugs take more than a year longer to develop and are less than half as likely to receive marketing approval compared to other drugs, according to a 2014 study by the Tufts Center for the Study of Drug Development. Why is it Difficult to Develop CNS Therapeutics?

Trials 83

Trials Drug Delivery Drugs Gene 83

XTalks

NOVEMBER 7, 2022

Prospective clinical trials are needed to explore whether changing therapy based on ctDNA dynamics prior to radiologic or clinical progression will improve outcomes compared to our current standard,” added Dr. Bahassi. These two tests may be making their way onto the market soon, potentially changing the paradigm in cancer screening.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

XTalks

MAY 13, 2022

Curia is a global contract research, development and manufacturing organization (CDMO) that specializes in drug discovery, spanning the entire product lifecycle from target to lead candidate identification, development, manufacturing feasibility, through to commercialization and post-marketing.

Packaging 98

Packaging Packaging Containment Production 98

Intouch Solutions

SEPTEMBER 27, 2024

Both manufacturers and marketers need to understand how HCPs make these decisions and which patients are likely to benefit from one type of treatment over another. Pharmaceutical marketers and commercialization teams need to consider how ctDNA impacts clinical decision-making. Will it revolutionize solid tumor staging?

DNA 59

DNA Trials Antibody Marketing 59

The Pharma Data

DECEMBER 23, 2020

Department of Defense (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in coordination with the Office of the Assistant Secretary of Defense for Health Affairs (OASD(HA)) and the Defense Health Agency (DHA). . PLYMOUTH MEETING, Pa. ,

DNA 40

DNA Vaccine Vaccination Immune Response 40

XTalks

SEPTEMBER 11, 2024

In 2016, the FDA’s Center for Devices and Radiological Health (CDRH) established the Health of Women Program to study issues related to the performance of medical devices in women, highlighting the necessity of gender-specific data. This surge reflects a growing recognition of the market potential in addressing women’s health.

Clinical Trials 103

Clinical Trials Clinical Trials Trials Hormones 103

XTalks

SEPTEMBER 14, 2020

All this cannot begin to explain the weird reality that the stock markets in the US (and elsewhere) are doing just fine. In fact, financial markets have almost regained most of the losses caused by COVID-19. Here again, the stock markets are functioning in a parallel universe. billion in June. ECONOMIC IMPACT: Canada.

Vaccine 92

Vaccine Vaccination Antibody Life Science 92